On February 18, Medicalsystem Biotechnology Co.Ltd(300439) announced that the company had recently obtained the medical device registration certificate of the people’s Republic of China (in vitro diagnostic reagent) (hereinafter referred to as the “registration certificate”) issued by Zhejiang provincial drug administration. The product name is “25 hydroxyvitamin D detection kit (chemiluminescence immunoassay)”, which is used to quantitatively determine the concentration of 25 hydroxyvitamin D in human serum samples in vitro. The registration certificate is valid until February 10, 2027.
Medicalsystem Biotechnology Co.Ltd(300439) said that obtaining the above registration certificate enriches and continues the company’s varieties in the chemiluminescence product line, which is conducive to further improving the company’s core competitiveness and market expansion ability, and will have a positive impact on the company’s future operation.
